Albertsons Companies, Inc. (ACI) — closed signal from December 10, 2025
Partial Published before the outcome was known, scored automatically when the window closed on March 10, 2026 — -1.5% at the close.
Predicted vs. what happened
What happened
Reached 43% of the predicted growth at its peak, without hitting the target.
The thesis — published December 10, 2025
Albertsons looks like a short-term trade rather than a long-term safe pick. Investors are very excited about its private-label products and recent product programs, but the company still has balance-sheet and merger questions. A bounce in the next 0-3 months is possible because many people are buying, yet the deal uncertainty keeps conviction low.
Primary drivers
- Big U.S. grocery and pharmacy chain with growing private-label brands.
- New nationwide product rollout and Innovation Launchpad show product effort.
- Strong investor enthusiasm and high trading volume point to active buying.
- Merger and regulatory questions make gains possible but risky.
How it played out
ACI: target missed after a partial rise
Lyra published ACI at $17.49 on 2025-12-10 as a short-term trade with 18% expected growth. The thesis pointed to private-label brands, a nationwide product rollout, Innovation Launchpad, active buying, and high trading volume. It also said balance-sheet, merger, and regulatory questions kept conviction low.
Inside the window, ACI rose but did not reach the $20.64 target. The peak was $18.83 on 2026-02-17, with a 7.7% gain. It never got there. By 2026-03-10, the stock ended at $17.23. The thesis partially played out, but the target was missed.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.